Beta-amyloid inhibition of MTT reduction is not mimicked by inhibitors of mitochondrial respiration.
Hawtin
S R
SR
Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex.
Dobbins
A C
AC
Tailor
V J
VJ
Shearman
M S
MS
D000493:Allopurinol / Q000494:pharmacology; D016229:Amyloid beta-Peptides / Q000494:pharmacology*; D000818:Animals; D000968:Antimycin A / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D002945:Cisplatin / Q000494:pharmacology; D004396:Coloring Agents; D003847:Deoxyglucose / Q000494:pharmacology; D001728:Dicumarol / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology; D006801:Humans; D008928:Mitochondria / Q000378:metabolism*; D010078:Oxazines; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects*; D016716:PC12 Cells; D010446:Peptide Fragments / Q000494:pharmacology*; D051381:Rats; D012402:Rotenone / Q000494:pharmacology; D013778:Tetrazolium Salts; D013844:Thiazoles; D014966:Xanthenes
D016229:Amyloid beta-Peptides; D000970:Antineoplastic Agents; D004396:Coloring Agents; D010078:Oxazines; D010446:Peptide Fragments; D013778:Tetrazolium Salts; D013844:Thiazoles; D014966:Xanthenes; C074636:amyloid beta-protein (25-35); D012402:Rotenone; C070380:3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium; C034697:transplatin; C005843:resazurin; D000493:Allopurinol; D000968:Antimycin A; D001728:Dicumarol; D004317:Doxorubicin; D003847:Deoxyglucose; C022616:thiazolyl blue; D002945:Cisplatin